从呼吸到大脑:流感疫苗接种作为预防痴呆症的务实战略
Lorenzo Blandi1, Marco Del Riccio2
1School of Public Health, Vita-Salute San Raffaele University, Via Olgettina 58, Milan, 20132, Italy.
Aging clinical and experimental research
|January 16, 2026
概括
接种流感疫苗可以通过减轻血管和神经炎症损伤来降低痴呆风险. 这一公共卫生战略为健康老龄化和认知障碍预防提供了一个务实的方法.
科学领域:
- 老年学是一门学科.
- 流行病学 流行病学
- 神经科学是一个神经科学.
背景情况:
- 人口老龄化面临着痴呆症患病率的增加,需要可扩展的预防策略.
- 流感感染与神经损伤有关,包括心肌梗塞和中风风险增加.
- 接种疫苗可以抵消与流感相关的微质激活和突触损失,即使来自非神经向菌株.
研究的目的:
- 审查支持流感疫苗接种作为痴呆症风险修改干预措施的证据.
- 要突出与流感疫苗接种与降低痴呆风险相关的生理病理和流行病学数据.
- 鼓励将流感疫苗接种纳入健康老龄化和慢性护理战略.
主要方法:
- 检查连接流感与认知障碍的生理病理机制.
- 对流感疫苗接种和痴呆风险的流行病学数据的分析,包括元分析和队列研究.
- 对接种疫苗者心血管事件的随机试验数据的检查.
主要成果:
- 流行病学研究表明,接种流感疫苗后,发病痴呆的风险降低了31%,阿尔茨海默病的风险降低了.
- 观察数据表明,疫苗接种与所有原因和血管痴呆的风险降低之间存在剂量反应关联.
- 随机试验表明接种疫苗的患者心血管事件较少,支持生物可信性.
结论:
- 流感疫苗接种是一种务实的干预措施,用于在健康衰老策略中修改痴呆症风险.
- 尽管有证据,但老年人接种流感疫苗受限于低风险感知和疫苗信心.
- 将疫苗接种情况纳入医疗保健途径并解决实施障碍对于实现预防效益至关重要.
相关概念视频
01:30Pneumonia V: Nursing management and Prevention
3.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
01:51Vaccinations
51.3K
Overview
51.3K
01:22Alzheimer's Disease: Treatment
825
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
825
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
188
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
188
01:15Drug Dosing: Geriatric Patients
228
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
228
01:30Dementia
526
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
526